Opus Genetics, Inc. Effective Tax Rate
Opus Genetics, Inc. (IRD) reported Effective Tax Rate of 0.00% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-08-06
- Opus Genetics, Inc. effective income tax rate reconciliation, percent for the quarter ending 2026-06-30 was 0.00%.
- Opus Genetics, Inc. effective income tax rate reconciliation, percent for the quarter ending 2026-03-31 was 0.00%.
- Opus Genetics, Inc. effective income tax rate reconciliation, percent for the quarter ending 2025-09-30 was 0.00%.
- Opus Genetics, Inc. effective income tax rate reconciliation, percent for the quarter ending 2025-06-30 was 0.00%.
- Opus Genetics, Inc. effective income tax rate reconciliation, percent for fiscal 2025 was 0.00%.
- Opus Genetics, Inc. effective income tax rate reconciliation, percent for fiscal 2024 was 0.00%, a 100.00% decline from fiscal 2023.
- Opus Genetics, Inc. effective income tax rate reconciliation, percent for fiscal 2023 was 0.10%, a 94.12% decline from fiscal 2022.
- Opus Genetics, Inc. effective income tax rate reconciliation, percent for fiscal 2022 was 1.70%.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00% 10-Q · filed 2026-08-06 | 0.00% 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | 0.00% 10-Q · filed 2026-05-12 | |||
| 2025-12-31 | 0.00% 10-K · filed 2026-03-12 | |||
| 2025-09-30 | 0.00% 10-Q · filed 2025-11-12 | 0.00% 10-Q · filed 2025-11-12 | ||
| 2025-06-30 | 0.00% 10-Q · filed 2026-08-06 | 0.00% 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | 0.00% 10-Q · filed 2026-05-12 | |||
| 2024-12-31 | 0.00% 10-K · filed 2026-03-12 | |||
| 2024-09-30 | 0.00% 10-Q · filed 2025-11-12 | 0.00% 10-Q · filed 2025-11-12 | ||
| 2024-06-30 | 0.00% 10-Q · filed 2025-08-13 | 0.00% 10-Q · filed 2024-08-13 | ||
| 2024-03-31 | 0.00% 10-Q · filed 2025-05-15 | |||
| 2023-12-31 | 0.10% 10-K · filed 2025-03-31 | |||
| 2023-09-30 | 0.00% 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | 0.00% 10-Q · filed 2024-08-13 | 0.00% 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | 0.00% 10-Q · filed 2024-05-10 | |||
| 2022-12-31 | 1.70% 10-K · filed 2024-03-08 | |||
| 2022-09-30 | 0.00% 10-Q · filed 2022-11-04 | 0.00% 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | 0.00% 10-Q · filed 2023-08-11 | 0.00% 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | 0.00% 10-Q · filed 2023-05-15 | |||
| 2021-12-31 | 0.00% 10-K · filed 2023-03-30 | |||
| 2021-09-30 | 0.00% 10-Q · filed 2022-11-04 | 0.00% 10-Q · filed 2022-11-04 | ||
| 2021-06-30 | 0.00% 10-Q · filed 2022-08-12 | 0.00% 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | 0.00% 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | 0.00% 10-K · filed 2022-03-24 | |||
| 2020-09-30 | 0.00% 10-Q · filed 2021-11-12 | 0.00% 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | 0.00% 10-Q · filed 2021-08-12 | 0.00% 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | 0.00% 10-Q · filed 2021-05-07 | |||
| 2019-12-31 | 0.00% 10-K · filed 2021-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |